Silvio Garattini    

Born in Bergamo (Italy) on 12th Nov 1928. Diploma in Chemistry. Degree in Medicine. Lecturer in Chemotherapy and Pharmacology. Assistant then Deputy Professor at the Milan University Institute of Pharmacology until 1962.
Founder in 1963 and director of the Mario Negri Institute for Pharmacological Research.
Garattini's publications in Italian and in English in international scientific journals, and texts on pharmacology, run into the hundreds. Founder of the European Organisation for Research and Treatment of Cancer (EORTC).
In the last ten years professor Garattini has been chairman of the UICC Committee on Antitumoral Chemotherapy, the European Organisation for Research and Treatment of Cancer (EORTC), the European Society of Biochemical Pharmacology. He served as a member of the Italian National Research Council (CNR) Committee on Biology and Medicine, the National Health Council, the Committee for Italian Research Policy, set up by the Presidency of the Council of Ministers, the Commissione Unica del Farmaco (CUF), and is a consultant to the World Health Organisation.
He is currently a member of the Committee for Proprietary Medicinal Products (CPMP) of the European Agency for the Evaluation of Medicinal Products (EMEA), Member of the CEPR (Committee of Experts of Research Policy) at the Ministry for the University and Scientific and Technological Research, President of the Angelo and Angela Valenti Foundation, President of the "Via di Natale" Foundation, President of the V Section of the Consiglio Superiore della Sanità. Member of the Board of Istituto Superiore di Sanità, Rome. Member Scientific Committee of the Lega Italiana per la Lotta Contro i Tumori (2000-2005). President, Steering Advisory Group Current Controlled Trials.
Silvio Garattini is a Fellow of the New York Academy of Sciences, the American Association for the Advancement of Science, Honorary Fellow of the Royal College of Physicians (Pharmaceutical Medicine), London, and a member of numerous other Italian and international scientific societies. He has received many awards for his work, including the French Legion d'Honneur for scientific merit, and the Commendatore della Repubblica Italiana, and holds honorary degrees from the universities of Bialystok in Poland, and Barcelona in Spain. Prize Ippocrate, 2003. Prize Mens Sana in Corpore Sano, Prize Nuova Spoleto, 2003.
In its 35-plus years, the Mario Negri Institute for Pharmacological Research, under Professor Garattini's leadership, has published more than 8500 scientific papers and about 175 books, on topics ranging from cancer and its treatment to tumor immunology, neuropsychopharmacology, and cardiovascular and renal pharmacology. More than 2100 young graduates and technicians have obtained specialist qualifications at the Institute.